The University of Maryland Gamma Knife Center offers an alternative for many patients for whom traditional brain surgery is not an option. The UM Gamma Knife Center, the first center of its kind in the Mid-Atlantic Region, has treated close to 2,500 patients since 1992.
Gamma Knife radiosurgery is recognized world-wide as the preferred treatment for metastatic brain tumors and has proven effective for certain primary brain tumors and arteriovenous malformations.
This revolutionary, non-invasive surgery is safe, efficient, and proven by decades of research and clinical data.
The Gamma Knife removes the physical trauma and the majority of risks associated with open surgery. It requires a hospital stay that is a fraction of that needed for recuperation after traditional surgery, cutting the overall cost by as much as 50%. Because Gamma Knife treatment is so effective, it is recognized and covered by the majority of insurance plans.
The side effects produced by this procedure, if any, are minimal and transient, and Gamma Knife treatment has been proven safe over the long term. There have been no mortalities directly attributed to the Gamma Knife during its quarter century of operation worldwide.
The interdisciplinary team at the University of Maryland Gamma Knife Center, led by Dr. William Regine, puts this state-of-the-art technology to work for patients from Maryland and throughout the Mid-Atlantic region.
This page was last updated: March 9, 2015